Abstract
The global market for cell and gene therapy is on the rise, driven by advances in CAR-T and RNA vaccines. Brazil leads this market regionally, but technological studies are still limited, affecting the population's access to these innovative therapies. While CAR-T cells are effective in treating liquid tumors, their efficacy against solid tumors is restricted, prompting interest in other …
